Acorda Says Tribunal Ignored Patent Law In MS Drug Feud

By Caroline Simson · March 19, 2024, 8:39 PM EDT

Acorda Pharmaceuticals is pressing the Federal Circuit to award it nearly $66 million more than the $16.5 million it won in arbitration against Irish biopharmaceutical company Alkermes in a licensing fight...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

Acorda Therapeutics, Inc. v. Alkermes plc

Case Number

Court

Appellate - Federal Circuit

Nature of Suit

896 Arbitration (Federal Question)

Date Filed

September 11, 2023

Recent Articles By Caroline

May 15, 2024
High Court Urged To Take Up Hospital Construction Feud
May 03, 2024
BVI Co. Looks To Force $195M PPE Fight Into Arbitration
April 05, 2024
Equatorial Guinea Says $8M Award Can't Be Enforced
April 04, 2024
NY AG Asked To Weigh In On Multiple Sclerosis Drug Fight
March 21, 2024
UpHealth Claims $110M Win In Glocal Control Fight
March 04, 2024
French Spinal Care Co. Can't Get €4.2M Award Enforced
November 20, 2023
DC Judge OKs $8M Award Against Equatorial Guinea
October 20, 2023
Arbitrator Misconduct Sinks $10M Nursing Home Sale Award
June 20, 2023
Sanofi Needn't Indemnify German Pharma Co. In Zantac Suits
October 17, 2022
Biotech Co. Wins $16.5M In Multiple Sclerosis Drug Fight